Number 30

It’s about living not just surviving

Editorial 1 May 2009 0

Patients are living with advanced cancer for ever more prolonged periods of time. But information and support services have been slow to catch up with clinical progress, and the needs of this rapidly growing group [more]

... [ more ]

Pat Price: asking the right questions

Cover Story 1 May 2009 0

Pat Price pioneered the use of PET imaging to investigate how cancer drugs move in the body and the effect they have. She worries that oncology has lost its way: translational research’ has become a [more]

... [ more ]

Decision making for systemic treatment of non-small-cell lung cancer

Grandround 1 May 2009 0

Non-small-cell lung cancers (NSCLC) covers a heterogeneous group of diseases, accounting for around 80% of all lung cancers, which were previously lumped together because there was no apparent reason to use different therapeutic approaches for [more]

... [ more ]

Health rationing in Europe: can cancer get a fair hearing?

Senza categoria 1 May 2009 0

Faced with escalating drug prices and rising patient expectations, Europe’s governments are anxious to ensure value for money from their overstretched health budgets. But how can one measure the value of a few extra precious [more]

... [ more ]

Closing the gap with the West

Senza categoria 1 May 2009 0

Polish surgeon Marek Nowacki has always had a very dynamic approach to cancer care, travelling extensively to pick up new tricks and techniques, and publishing his own innovations to spread the benefit. Today, thanks to [more]

... [ more ]

Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck

Impact Factor 1 May 2009 0

Cetuximab increases overall survival in patients with recurrent or metastatic squamous cell carcinomas of the head and neck. Reasonable treatment strategies include the use of first-line platinum, 5-fluorouracil and cetuximab combination, or cetuximab used following [more]

... [ more ]

Optimal timing of surgery after preoperative chemoradiotherapy for rectal cancer

Impact Factor 1 May 2009 0

The optimal timing for rectal cancer surgery after neoadjuvant chemoradiotherapy, in terms of risk of complications or tumour response, remains uncertain. Download full article

... [ more ]

Newsround

Senza categoria 1 May 2009 0

Selected repor ts edited by Janet Fricker Download full article

... [ more ]

Why are cancer patients still suffering unnecessary pain?

Systems & Services 1 May 2009 0

More than 20 years since the WHO published its three-step guideline for controlling cancer pain, European patients are still complaining of pain that is long lasting, interferes with their daily activities and can even be [more]

... [ more ]